MCQs on Biotechnology and its Applications: Class-XII for NEET Practice
This Page Score: 0/40
Match the Bt Toxin mechanism details in List-I with their corresponding description in List-II:
List-I (Mechanism Detail)
List-II (Description/Result)
A. Bt Toxin in bacterium
P. Exists as inactive protoxin
B. Toxin activation environment
Q. Alkaline pH of the gut
C. Binding action
R. Binds to midgut epithelial cells
D. Immediate cause of death
S. Cell swelling and lysis due to pore creation
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Bt toxin exists as an inactive protoxin in the bacterium *Bacillus thuringiensis*. B. The inactive toxin is converted to active form due to the alkaline pH of the insect gut. C. The activated toxin binds to the surface of midgut epithelial cells. D. The creation of pores causes cell swelling and lysis, eventually causing the death of the insect.
Match the Insulin production methods in List-I with their associated challenges/successes in List-II:
List-I (Method/Source)
List-II (Challenge/Success)
A. Pro-hormone challenge
P. Assembling the three chains into a mature functional form
B. Eli Lilly (1983)
Q. Produced chains A and B separately in *E. coli* plasmids
C. Insulin from cattle/pigs
R. Risk of causing allergy or immune reactions
D. Recombinant Therapeutics
S. Do not induce unwanted immunological responses
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. The main challenge for producing human insulin using rDNA techniques was getting the pro-hormone assembled into a mature form. B. Eli Lilly produced chains A and B separately in *E. coli* plasmids. C. Insulin from slaughtered animals caused allergy or reactions to the foreign protein. D. Recombinant therapeutics do not induce unwanted immunological responses.
Match the Gene Therapy applications in List-I with their corresponding details in List-II:
List-I (Therapy Detail)
List-II (Description/Method)
A. Gene Therapy Definition
P. Inserting genes into a person's cells and tissues to treat disease
B. Lymphocyte engineering
Q. Cells grown in culture outside the patient's body
C. Permanent Cure
R. Introduction of gene into cells at early embryonic stages
D. Gene Correction Mechanism
S. Delivery of a normal gene to compensate for a non-functional gene
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Gene therapy involves inserting genes into cells and tissues to treat a disease. B. Lymphocytes used in temporary gene therapy are first grown in a culture outside the body. C. A permanent cure for ADA could be achieved if the gene is introduced at early embryonic stages. D. Gene correction involves delivering a normal gene to compensate for the non-functional gene.
Match the organisms in List-I with their status/role in List-II:
List-I (Organism)
List-II (Status/Role)
A. GMO
P. Organisms whose genes have been altered by manipulation
B. Transgenic animals
Q. Possess and express an extra (foreign) gene
C. *E. coli*
R. Used to produce recombinant insulin chains
D. *Bacillus thuringiensis*
S. Produces protein crystals containing inactive protoxin
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. GMOs are organisms (plants, bacteria, fungi, animals) whose genes have been altered by manipulation. B. Transgenic animals have manipulated DNA to possess and express a foreign gene. C. *E. coli* plasmids were used by Eli Lilly to produce human insulin chains. D. *Bacillus thuringiensis* forms protein crystals containing a toxic insecticidal protein (inactive protoxin).
Match the plant types and related pests in List-I with their corresponding details in List-II:
List-I (Plant/Pest)
List-II (Detail/Effect)
A. *Meloidegyne incognitia*
P. Nematode infecting tobacco roots
B. Transgenic nematode-resistant plant
Q. Expresses specific interfering RNA
C. Bt Cotton
R. Bio-pesticide protecting against bollworms
D. Corn borer
S. Controlled by the *cryIAb* gene
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. *Meloidegyne incognitia* is a nematode that infects the roots of tobacco plants. B. The transgenic host expresses specific interfering RNA, making the parasite unable to survive. C. Bt cotton expresses the Bt toxin gene, acting as a bio-pesticide against bollworms. D. Corn borer is controlled by the protein encoded by the *cryIAb* gene.
Match the Transgenic Animal details in List-I with their context/purpose in List-II:
List-I (Animal/Product)
List-II (Context/Product)
A. Rosie (1997)
P. First transgenic cow
B. Human alpha-lactalbumin
Q. Made milk nutritionally balanced for human babies
C. Transgenic mice
R. Used to test the safety of the polio vaccine
D. Alpha-1-antitrypsin
S. Human protein used to treat emphysema
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Rosie was the first transgenic cow, produced in 1997. B. Human alpha-lactalbumin made Rosie's milk nutritionally balanced for human babies. C. Transgenic mice are being developed for vaccine safety testing (e.g., polio vaccine). D. Alpha-1-antitrypsin is a biological product used to treat emphysema.
Match the human diseases in List-I with their associated gene therapy/model status in List-II:
List-I (Disease)
List-II (Therapy/Model Status)
A. ADA deficiency
P. First disease treated by clinical gene therapy
B. Phenylketonuria (PKU)
Q. Similar attempts for treatment being made using transgenic animals
C. Cancer
R. Transgenic models exist to increase understanding of gene contribution
D. HIV diagnosis
S. Routinely detected using PCR amplification of nucleic acid
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. ADA deficiency was the first disease treated by clinical gene therapy in 1990. B. Similar attempts to those for emphysema are being made for the treatment of PKU using transgenic animals. C. Transgenic animals are designed to serve as models for cancer to understand gene contribution. D. PCR is routinely used to detect HIV in suspected AIDS patients.
Match the plant types/processes in List-I with their purpose or status in List-II:
List-I (Plant Type/Process)
List-II (Purpose/Status)
A. Tissue Culture
P. Technology developed when traditional breeding failed to keep pace
B. Somaclones
Q. Genetically identical to the original plant
C. Meristem
R. Free of virus even if the plant is infected
D. Protoplasts (naked)
S. Isolated after digesting plant cell walls
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Tissue culture was developed when traditional breeding techniques were deemed too slow and inefficient. B. Somaclones are genetically identical plants produced by micro-propagation. C. The meristem (apical and axillary) is characteristically virus-free. D. Protoplasts are isolated naked cells obtained by digesting plant cell walls.
Assertion (A): A novel strategy based on RNA interference (RNAi) was adopted to prevent infestation of tobacco plants by the nematode Meloidegyne incognitia. Reason (R): RNAi involves introducing nematode-specific genes via Agrobacterium vectors, which produce complementary sense and anti-sense RNA strands that form dsRNA, thereby silencing the parasite's specific mRNA.
[Biotechnology-and-its-Applications] [class-xii ]
(A) Both Assertion and Reason are true, and Reason is the correct explanation of Assertion
(B) Both Assertion and Reason are true, but Reason is not the correct explanation of Assertion
(C) Assertion is true but Reason is false
(D) Assertion is false but Reason is true
Correct Option: A  [ A ]
Remark: The nematode Meloidegyne incognitia infects tobacco roots, causing great reduction in yield. RNAi is a method of cellular defense involving silencing of specific mRNA due to a complementary dsRNA. In transgenic plants, Agrobacterium vectors introduce DNA that produces complementary sense and anti-sense RNA, forming dsRNA and silencing the nematode’s specific mRNA, thus protecting the plant.
Assertion (A): Genetically modified (GM) plants have been developed to be more tolerant to abiotic stresses. Reason (R): Genetic modification allows the crops to incorporate genes that provide increased tolerance to environmental conditions like cold, drought, salt, and heat.
[Biotechnology-and-its-Applications] [class-xii ]
(A) Both Assertion and Reason are true, and Reason is the correct explanation of Assertion
(B) Both Assertion and Reason are true, but Reason is not the correct explanation of Assertion
(C) Assertion is true but Reason is false
(D) Assertion is false but Reason is true
Correct Option: A  [ A ]
Remark: GM plants are modified to better withstand environmental stresses, such as high temperature, drought, and salinity, reducing crop losses.